Eterna Therapeutics Inc. announced a private placement of $1,500,000 promissory note on December 8, 2023. The transaction included participation from new lender Charles Cherington. The note issued is senior unsecured obligation of the company and ranks equal in right of payment with all of the company?s existing and future unsubordinated indebtedness.

The note carry a interest rate of 6% per annum. The note will mature on January 8, 2024.